Terveystalo Group Interim Report 1 January – 31 March, 2023: Solid earnings development driven by strong demand, Terveystalo issues guidance for 2023
Terveystalo Plc, Interim Report 28 April, 2023 at 09:00 EEST This release is a summary of Terveystalo's Interim Report 1 January – 31 March, 2023. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/company/investors/reports-and-presentations/ January-March 2023 in brief · Revenue increased by 3.4% year-on-year to EUR 341.1 (329.7) million. The Healthcare Services segment revenue increased by 4.5% and was EUR 249.8 (239.0) million. Portfolio Businesses revenue decreased by 4.1% and was EUR 70.8 (73.8)